Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Inogen, Inc.

Inogen, Inc. (INGN) Stock Overview

Explore Inogen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

INGN●NASDAQ
HealthcareMedical - Devices
$5.81
$0.00(0.00%)
U.S. Market opens in 2h 7m

Inogen, Inc. (INGN)

Meyka AI Score

Z

Key Financials

Market Cap157.3M
P/E Ratio-6.54
EPS (TTM)$-0.91
ROE-0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$8.28
3 Months$8.10
1 Year Target$5.43

INGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Inogen, Inc. (NASDAQ: INGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Inogen, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of INGN on the NASDAQ shows an RSI of 35.07, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.43 for the NASDAQ listing.

Key metrics behind Inogen, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.54 and a market capitalization of 157.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of INGN on the NASDAQ.

Price Performance (NASDAQ: INGN)

1-Day Change
N/A
5-Day Change
-1.53%
1-Month Change
-11.16%
3-Month Change
-14.68%
6-Month Change
0.87%
Year-to-Date (YTD) Change
-13.54%
1-Year Change
-24.55%
3-Year Change
-5.53%
5-Year Change
-90.68%
All-Time (Max) Change
-61.65%

Contact Information

https://www.inogen.com
805 562 0500
500 Cummings Center, Beverly, MA, 01915

Company Facts

7,530 Employees
IPO DateFeb 14, 2014
CountryUS
Actively Trading

Frequently Asked Questions